Please note that the ABCD Conference 2024 programme is subject to change

We welcome abstracts on any subject relating to Diabetes, Endocrinology and General Medicine, which might be o

Duodenal Jejunal bypass liner for Diabesity – Risk versus benefit data from the Association of British Clinical Diabetologists (ABCD) Worldwide EndoBarrier Registry.

Authors: B. Ryder, M. Lynne, H. Frydenberg, S. Fishman, R. Cohen, C. de Jonge, J. Greve, J. Bascomb, J. Bessell, J. McMaster, G. Holtman, G. Rich, J. Collins, L. Kow, P. Pferschy, H. Sourij, J. Byrne, J. Mason, J. Teare, M. Benes

UK first National Health Service (NHS) EndoBarrier Service for uncontrolled Diabesity shows the metabolic improvements 6-months after EndoBarrier removal are well maintained.

Authors: REJ Ryder, M Yadagiri, SP Irwin, W Burbridge, T Bashir, MC Wyres, ML Cull, JP Bleasdale, RA Allden, EN Fogden, M Anderson and P Sen Gupta

Impact of Endobarrier on need for Continuous Positive Airway Pressure Ventilation(CPAP) in Diabetes/Pre-Diabetes with Obstructive sleep apnoea(OSA) study: Current data at Endobarrier removal and 6-months later.

Authors: M Yadagiri, F Kinney, J Adams, N. Ashman, JP Bleasdale, EN Fogden, MR Anderson, M Greenstone, C Walton, REJ Ryder

Evaluation of the efficacy and safety of endoscopically achieved proximal intestinal exclusion as an adjunct to glucagon-like peptide-1 therapy in diabesity: REVISE-Diabesity clinical trial.

Authors: P Sen Gupta, B McGowan, R. Drummond, SA Amiel, REJ Ryder. 

Ahead of the launch of our Diabetes Dragons' Den for 2024, we're speaking to those who successfully pitched to our 'dragons' for funding last year.

In our final interview we hear from Emma Johns, NHS Greater Glasgow and Clyde, who was successfully awarded funding alongside Elaine Butterly for their project exploring Hybrid Closed Loop to prevent recurrent diabetic ketoacidosis (DKA) in high risk people with type one diabetes. Emma details their experience of the 'dragons' den' and how the grant will help their career - read the full interview below.

Many clinicians all over the country are engaged in highly innovative and impactful work in the field of diabetes.

Help us to recognise a young and innovative researcher. Please share this work and nominate yourself or someone else for a ‘rising star’ lecture at the ABCD Annual Conference 2024

JBDS - IP Joint British Diabetes Societies for inpatient care

The Joint British Diabetes Societies (JBDS) for Inpatient Care group was created in 2008 to ‘deliver a set of diabetes inpatient guidelines and proposed standards of care within secondary care organisations’, with the overall aim of improving inpatient diabetes care through the development and use of high quality evidence based guidelines, and through better inpatient care pathways.